|
US2008213415A1
|
|
Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
|
|
US2007281903A1
|
|
Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
|
|
US2007184137A1
|
|
Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes
|
|
US2007166417A1
|
|
Formulation and Methods for Use of Morinda Citrifolia Seed Oil
|
|
US2007154579A1
|
|
Morinda Citrifolia Based Formulation And Methods For Weight Management
|
|
US2007202206A1
|
|
Morinda Citrifolia Leaf Juice And Leaf Extract Based Formulations
|
|
US2006269630A1
|
|
Morinda citrifolia as a 5-Lipoxygenase inhibitor
|
|
US2006280818A1
|
|
Nicotinic acetylcholine receptor antagonist
|
|
US2007122507A1
|
|
Histone deacetylase and tumor necrosis factor converting enzyme inhibition
|
|
US2006141076A1
|
|
Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
|
|
US2006204601A1
|
|
Formulations and methods for preventing and treating substance abuse and addiction
|
|
US2005260291A1
|
|
Methods and compositions for reactivating acetylcholinesterase
|
|
US2007184135A1
|
|
Morinda citrifolia-based formulation 5-LOX and 15-LOX
|
